A detailed history of Gibbs Wealth Management transactions in Novartis Ag stock. As of the latest transaction made, Gibbs Wealth Management holds 3,181 shares of NVS stock, worth $418,460. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,181
Previous 3,894 18.31%
Holding current value
$418,460
Previous $471 Million 13.42%
% of portfolio
0.09%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 30, 2025

SELL
$113.5 - $129.73 $80,925 - $92,497
-713 Reduced 18.31%
3,181 $408 Million
Q2 2025

Aug 13, 2025

BUY
$101.96 - $121.01 $397,032 - $471,212
3,894 New
3,894 $471 Million
Q1 2025

Nov 04, 2025

BUY
$97.14 - $115.57 $63,238 - $75,236
651 Added 28.96%
2,899 $323 Million
Q4 2024

Nov 04, 2025

SELL
$96.78 - $117.18 $90,295 - $109,328
-933 Reduced 29.33%
2,248 $219 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Gibbs Wealth Management Portfolio

Follow Gibbs Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gibbs Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Gibbs Wealth Management with notifications on news.